loader
Please Wait
Applying Filters...

Fulvestrant Fulvestrant

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of Health Canada Patents covering Tox21_202604.

    Client Email Product
    Menu

    Tox21_202604

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    PharmaCompass Sponsored Ads

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AstraZeneca Canada Inc. (1)

    filter

    01 2351004 (1)

    filter

    01 Fulvestrant (1)

    filter

    01 Injectable Solution (1)

    filter

    01 2021-08-01 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Fulvestrant

    PDF Supplier PDF
    URL Supplier Web Content
    2351004
    50 mg / mL
    Injectable Solution
    Human
    2021-08-01
    2003-02-18
    2001-08-01
    FASLODEX
    Intramuscular Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY